Measuring the effectiveness of hybrid diabetes care over 90 days through continuous data monitoring in type 2 diabetic patients
Frontiers in Endocrinology · 07.05.2024 · 15
DOI: 10.3389/fendo.2024.1355792 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Frontiers in Endocrinology, online erschienen am 07.05.2024. Verfasst von Hala Zakaria und 9 weiteren Autor:innen. Beteiligte Einrichtung: GluCare Integrated Diabetes Center, Dubai, United Arab Emirates. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Telemedicine, Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes Mellitus, a global health challenge, affects 537 million individuals. Traditional management relies on periodic clinic visits, but technological advancements, including remote monitoring, offer transformative changes. Telemedicine enhances access, convenience, adherence, and glycemic control. Challenges include trust-building and limitations in face-to-face interactions. Integrating remote monitoring with in-person healthcare creates a hybrid approach. This study evaluates the impact on Type 2 Diabetes patients over 3 months.
Methods
A retrospective case-control observational study. Inclusion criteria involved previous Type 2 Diabetes diagnosis and a minimum 3-month GluCare model period with two physical visits. Patients in the case group had in-clinic visits, bi-weekly app engagement, and monthly body weight readings. Control group had in-clinic visits only. Outcomes measured included HbA1c, lipid profile, CV risk, eGFR, urine Albumin/Creatinine Ratio, Uric Acid, and CRP.
Results
Case group showed significant HbA1c improvements (-2.19%), especially in higher baseline levels. Weight, BMI, LDL, total cholesterol, and CVD risk also improved. Controls showed smaller improvements. Higher digital interactions correlated with better outcomes. Patients with ≥11 interactions showed significant reductions in HbA1c (-2.38%) and weight (-6.00 kg).
Conclusion
The GluCare.Health hybrid model demonstrates promising outcomes in Type 2 diabetes management. The integration of in-clinic consultations with continuous remote monitoring leads to substantial improvements in glycemic control and clinical parameters. The study highlights the importance of patient engagement in achieving positive outcomes, with higher digital interactions associated with greater reductions in HbA1c and weight. The hybrid approach proves more effective than digital-only interventions, emphasizing the need for comprehensive, end-to-end solutions in diabetes care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GluCare Integrated Diabetes Center, Dubai, United Arab Emirates.
Zitieren
APA
Zakaria, H., Said, Y., Aleabova, S., Bangayan, J., Dandan, M., Debs, J., Dahlstrom, N., Divino, D., Hashemi, A., & Almarzooqi, I. (2024). Measuring the effectiveness of hybrid diabetes care over 90 days through continuous data monitoring in type 2 diabetic patients. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1355792
Vancouver
Zakaria H, Said Y, Aleabova S, Bangayan J, Dandan M, Debs J, et al. Measuring the effectiveness of hybrid diabetes care over 90 days through continuous data monitoring in type 2 diabetic patients. Frontiers in Endocrinology. 2024;15. doi:10.3389/fendo.2024.1355792
BibTeX
@article{Zakaria2024,
author = {Zakaria, Hala and Said, Yousef and Aleabova, Sofia and Bangayan, Jestoni and Dandan, Mirabelle and Debs, Joelle and Dahlstrom, Nichole and Divino, Dianne and Hashemi, Ali and Almarzooqi, Ihsan},
title = {Measuring the effectiveness of hybrid diabetes care over 90 days through continuous data monitoring in type 2 diabetic patients},
journal = {Frontiers in Endocrinology},
year = {2024},
volume = {15},
doi = {10.3389/fendo.2024.1355792}
}
EUVIMED